All Publications — CAMS Oxford Institute

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination

Chen J-L. et al, (2025), Nature Communications, 16

Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.

Jeewandara C. et al, (2022), Immunology, 167, 263 - 274

Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222

Jayathilaka D. et al, (2022), Clinical and Experimental Immunology, 208, 323 - 331

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals

Jeewandara C. et al, (2022), Immunity, Inflammation and Disease, 10

Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection.

Jeewandara C. et al, (2022), BMC infectious diseases, 22

Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR.

Ranasinghe D. et al, (2022), PloS one, 17

Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka.

Ranasinghe D. et al, (2022), Frontiers in public health, 10

Comparison of the lmmunogenicity of five COVID-19 vaccines in Sri Lanka

Jeewandara JMKC. et al, (2022), JOURNAL OF IMMUNOLOGY, 208

Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka

Jeewandara C. et al, (2021), The Journal of Immunology, 207, 2681 - 2687

Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka

Jeewandara C. et al, (2021), Frontiers in Public Health, 9

Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients

Kamaladasa A. et al, (2021), International Journal of Infectious Diseases, 109, 85 - 89

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers

Jeewandara C. et al, (2021), Nature Communications, 12

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.

Jeewandara C. et al, (2021), Scientific reports, 11

Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020.

Jeewandara C. et al, (2021), PloS one, 16

Genomic and Epidemiological Analysis of SARS-CoV-2 Viruses in Sri Lanka.

Jeewandara C. et al, (2021), Frontiers in microbiology, 12

Load More